Rani Therapeutics Holdings (RANI) Shares Issued (2021 - 2026)

Rani Therapeutics Holdings' Shares Issued history runs 6 years deep, the most recent figure standing at $12.7 million for Q1 2026.

• On a quarterly basis, Shares Issued rose 11.85% year-over-year to $12.7 million in Q1 2026; TTM through Mar 2026 was $12.7 million, a 11.85% increase from a year earlier, with the FY2025 full-year figure at $12.9 million, up 25.84% from the prior year.
• Shares Issued fell to $12.7 million in Q1 2026 per RANI's latest filing, from $12.9 million in the prior quarter.
• Across five years, Shares Issued topped out at $12.9 million in Q4 2025 and bottomed at $851908.0 in Q3 2022.
• The 5-year median for Shares Issued is $6.4 million (2025), against an average of $6.9 million.
• Across the five-year window, Shares Issued slumped 99.84% in 2022 and surged 75.26% in 2023, its largest moves.
• Year by year, Shares Issued stood at $3.8 million in 2022, then soared by 75.26% to $6.6 million in 2023, then soared by 54.0% to $10.2 million in 2024, then grew by 25.84% to $12.9 million in 2025, then dropped by 1.06% to $12.7 million in 2026.
• Per Business Quant, the three latest RANI Shares Issued figures stand at $12.7 million (Q1 2026), $12.9 million (Q4 2025), and $6.4 million (Q3 2025).